TXG

10x Genomics's stock price has experienced fluctuations over the past six months. On May 5, 2026, the stock price was $22.01 per share, a 171.73% increase from $8.10 per share on May 6, 2025. The 52-week trading range has been between $8.06 and $26.45. Recent events include a stock drop after Q1 2026 results due to concerns about future growth, despite beating estimates; the Q1 2026 revenue report showing a decrease year-over-year but an increase excluding a one-time settlement; gains ahead of the Q1 2026 earnings report; a rise in stock price following the launch of the Atera platform; and a surge driven by investor enthusiasm for the company's role in spatial biology initiatives. The company released its Fourth Quarter and Full Year 2025 earnings on February 12, 2026, and its Third Quarter 2025 earnings on November 6, 2025. The stock is considered highly volatile.